Results 51 to 60 of about 5,540,950 (140)

Changes in Clinical Activity, Serum Autoantibody Levels, and Chorioretinal Vessels After Systemic Glucocorticoid Therapy in Thyroid Eye Disease

Ophthalmology and Therapy, 2023
Introduction The aim of this study was to investigate changes in the Clinical Activity Score, serum thyroid-stimulating hormone receptor antibody and thyroid-stimulating immunoglobulin levels, chorioretinal blood vessels, and extraocular muscle thickness
Jaekyoung Lee, Dong Cheol Lee
doaj   +1 more source

Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer [PDF]

, 2009
Background: Thyroid nodules are a common clinical problem, and differentiated thyroid cancer is becoming increasingly prevalent. Since the publication of the American Thyroid Association's guidelines for the management of these disorders was published in
Steward DL, Tuttle RM, Schlumberger M, Martin Schlumberger, Stephanie L. Lee, Haugen, Bryan R., McIver B, Cooper, David S., Haugen BR, Cooper DS, American Thyroid Association Guidelines Taskforce on Thyroid Nodules, Mandel, Susan J., Steward, David L., Bryan McIver, Richard T. Kloos, Mazzaferri EL, Steven I. Sherman, Doherty, Gerard M., Sherman, Steven I., Susan J. Mandel, Lee SL, Kloos RT, R. Michael Tuttle, McIver, Bryan, Ernest L. Mazzaferri, Kloos, Richard T., Lee, Stephanie L., Gerard M. Doherty, Pacini, Furio, Doherty GM, Bryan R. Haugen, Schlumberger, Martin, Furio Pacini, Differentiated Thyroid Cancer, David S. Cooper, Mazzaferri, Ernest L., Mandel SJ, Sherman SI, David L. Steward, Tuttle, R. Michael   +39 more
core   +1 more source

Orbital radiation for thyroid eye disease

, 2022
Orbital radiation therapy may be effective in combination with steroids for patients with active, severe thyroid eye disease, and particularly those with dysthyroid optic neuropathy.
Stanley, Nancy M., Offord, Kenneth P., Wiersinga, Wilmar M., Garrity, James A., Bahn, Rebecca S., Kline, Robert W., Gorman, Colum A., Bergstralh, Erik J., Blank, Leo, Dekker, Friedo W., Petersen, Ivy A., Scofield, Stacy, Terwee, Caroline B., Prummel, Mark F., Bartley, George B., Mourits, Maarten P., Rademacher, Diana M., Gerding, Martin N., Baldeschi, Lelio, Stewart, Michael W., Fatourechi, Vahab, Earle, John D., Forbes, Glenn S., Stafford, Scott L., Gold, Katherine G., Isaacson, Steven R., Kazim, Michael   +26 more
core   +1 more source

Thyroid-Associated Ophthalmopathy in Iranian Patients [PDF]

Acta Medica Iranica, 2011
"nWe determined the frequency of clinical thyroid ophthalmopathy in Iranian patients. This cross-sectional study was performed at the Endocrinology Institute of Tehran University of Medical Sciences.
Mohsen Bahmani Kashkouli, Sara Jam, Duman Sabzvari, Nooshin Ketabi, Shahrzad Azarinia, SeyedAhmad SeyedAlinaghi, Alireza Mofid   +6 more
doaj   +2 more sources

Ocular Motility in Thyroid Eye Disease Evaluation and Surgery

, 2010
Evaluation of diplopia in the patient with Thyroid Eye Disease requires differentiating between monocular and binocular diplopia, both of which may occur.curriculum_fellow; IC-E4di-thyroid ...
Steven E. Feldon, MD, MBA
core  

Objective Markers for Thyroid Eye Disease (TED) Activity, Severity 387 and Progression

, 2010
Thyroid eye disease (TED) also called Graves\u27 ophthalmopathy, can result in visual disability, including blurred or double vision, visual loss), discomfort, and facial ...
Kimberly P. Cockerham, MD, FACS
core  

Thyroid Eye Disease

, 2021
Dr.
Andrew G. Lee, MD; Zainub Abdullah
core  

Immunohistochemistry differentiates papillary thyroid carcinoma arising in ectopic thyroid tissue from secondary lymph node metastases.

, 2007
Objective: To verify whether immunohistochemistry might be useful in the distinction between a true laterocervical metastasis of an undetected thyroid carcinoma and a primary tumor outside the gland.
ARAGONA, Federico, CACCIATORE M, THYROID JUL, CABIBI, Daniela, GUARNOTTA, Carla   +4 more
core   +1 more source

Successful outcome of Rituximab treatment based on lymphocyte immunophenotyping in active Thyroid Eye Disease: a case report

Thyroid Research
Background Rituximab, an anti-CD20 monoclonal antibody that depletes B-cells, is a potential second-line treatment for moderate-to-severe active Thyroid Eye Disease that is resistant to steroids.
Mirco Armenti, Sara Maioli, Chiara Riva, Nicola Currò, Giorgia Moschetti, Mario Salvi, Ilaria Muller   +6 more
doaj   +1 more source

Clinical characteristics of thyroid eye disease and expression profile of peripheral blood immune cells

Scientific Reports
This study included patients with thyroid eye disease (n = 81) and Graves’ disease (n = 165) for a cross-sectional study. Then, peripheral blood mononuclear cells (PBMCs) were collected from patients with thyroid eye disease (n = 5), Graves’ disease (n = 
Hongli Lin, Honghong Duan, Jingyi Zheng, Zhengrong Jiang, Yajing Xu, Huibin Huang   +5 more
doaj   +1 more source